Suppr超能文献

伊奥内斯库-希利心包异种移植的长期临床结果。

Long-term clinical results with the Ionescu-Shiley pericardial xenograft.

作者信息

Masters R G, Pipe A L, Bedard J P, Brais M P, Goldstein W G, Koshal A, Keon W J

机构信息

University of Ottawa Heart Institute, Ottawa Civic Hospital, Ontario, Canada.

出版信息

J Thorac Cardiovasc Surg. 1991 Jan;101(1):81-9.

PMID:1986173
Abstract

From 1977 to 1987, 829 Ionescu-Shiley pericardial valves (Shiley, Inc., Irvine, Calif.) were implanted in 766 patients at the University of Ottawa Heart Institute. There were 476 patients who had aortic valve replacement, 234 who had mitral valve replacement, and 44 who had double valve replacement. The standard-profile design was used in 508 patients and the low-profile design in 321 patients. Follow-up was obtained for 97% of patients, with calculation of event-free probabilities. At 10 years the overall probability of freedom from structural failure was 48% +/- 7% after aortic valve replacement, 44% +/- 15% after mitral valve replacement, and 79% +/- 11% after double valve replacement. Although at 5 years the probability of failure was statistically lower with the low-profile design, this favorability was lost by 6 years. Freedom from structural failure was only 47% +/- 7% for the standard-profile valve at 10 years. Thus the probability of freedom from reoperation was only 46% +/- 7% after aortic valve replacement, 39% +/- 6% after mitral valve replacement, and 65% +/- 20% after double valve replacement at 10 years. Thromboembolism occurred in 69 patients, for a predicted freedom from this complication at 10 years of 79% +/- 3% after aortic, 73% +/- 7% after mitral, and 96% +/- 4% after double valve replacement. There were 31 cases of endocarditis. The 10-year predicted freedom from endocarditis, therefore, was 86% +/- 3% after aortic, 98% +/- 1% after mitral, and 97% +/- 1% after double valve replacement. A total of 221 operative and late deaths were recorded in this series. Prosthetic valve failure accounted for 27% of late deaths. The 10-year survival rates were estimated to be 56% +/- 5% (aortic valve replacement), 54% +/- 6% (mitral valve replacement), and 51% +/- 8% (double valve replacement). We concluded that the Ionescu-Shiley pericardial xenograft provides less than optimal clinical performance and its use has been discontinued.

摘要

1977年至1987年期间,渥太华大学心脏研究所的766例患者植入了829枚伊奥内斯库-希利心包瓣膜(希利公司,加利福尼亚州欧文市)。其中476例患者接受主动脉瓣置换,234例接受二尖瓣置换,44例接受双瓣膜置换。508例患者使用标准外形设计瓣膜,321例患者使用低外形设计瓣膜。对97%的患者进行了随访,并计算无事件概率。主动脉瓣置换术后10年,无结构故障的总体概率为48%±7%;二尖瓣置换术后为44%±15%;双瓣膜置换术后为79%±11%。尽管在5年时,低外形设计瓣膜的故障概率在统计学上较低,但到6年时这种优势就消失了。10年时,标准外形瓣膜无结构故障的概率仅为47%±7%。因此,主动脉瓣置换术后10年再次手术的概率仅为46%±7%,二尖瓣置换术后为39%±6%,双瓣膜置换术后为65%±20%。69例患者发生血栓栓塞,主动脉瓣置换术后10年预测无此并发症的概率为79%±3%,二尖瓣置换术后为73%±7%,双瓣膜置换术后为96%±4%。发生心内膜炎31例。因此,主动脉瓣置换术后10年预测无心内膜炎的概率为86%±3%,二尖瓣置换术后为98%±1%,双瓣膜置换术后为97%±1%。本系列共记录221例手术和晚期死亡病例。人工瓣膜故障占晚期死亡病例的27%。估计10年生存率分别为56%±5%(主动脉瓣置换)、54%±6%(二尖瓣置换)和51%±8%(双瓣膜置换)。我们得出结论,伊奥内斯库-希利心包异种移植物的临床性能不理想,已停止使用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验